Final Recommendation We are absolutely thrilled to announce this morning that burosumab has been APPROVED for routine use on our NHS for children from 1 years up to young adults aged 16/17 years. This news completely changes the landscape for the estimated 250 children living with XLH in the UK. Burosumab will be the first …

by Admin OG

Today we have launched the Rare Musculoskeletal Diseases in Adulthood Priority Setting Partnership

by Admin OG